Form Bio
Accelerating cell and gene therapy breakthroughs with AI-powered software that optimizes the design, safety, and manufacturability of advanced therapies
Form Bio is a computational life sciences company specializing in artificial intelligence and advanced software for cell and gene therapy development, particularly for adeno-associated virus (AAV) gene therapies. Their unified platform streamlines every stage of drug design—enabling scientists to model and evaluate billions of possible therapeutic vector designs in silico to maximize efficacy, safety, and manufacturability. The platform provides deep genomic, safety, and manufacturability analyses to ensure candidates are robust and ready for regulatory submission, dramatically reducing time, cost, and risk.Incubated by Colossal Biosciences.
Testimonial
Related Companies
Klona Biotech
The future of human tissue replacements using 3D printing
London, United Kingdom
Lyric Bio
Pioneering the future of biomanufacturing using proven and proprietary 3D bioprinting and tissue engineering technologies
San Carlos, California
Eywa Biotech
Scaling the production of pharmaceutical-grade psychedelic compounds through synthetic biology
Montevideo, Uruguay · Buenos Aires, Argentina
PrettyLitter
Develops a lightweight cat litter that helps cat owners monitor their pets' health by changing colors in response to abnormalities in urine.
Los Angeles, United States
nVision
nVision’s focus is on women’s health. The company created the first FDA-cleared device for collecting cells from the fallopian tubes, which aimed to enable earlier diagnosis of ovarian cancer. In 2018, nVision was acquired by Boston Scientific.
Senodia
MEMS sensors for various applications.
China, Shanghai
Aanika
Innovative science-backed insurance solutions for agriculture and food industries with Bio technology.
Brooklyn, United States
